Search for: "Novartis International AG" Results 1 - 20 of 120
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jan 2023, 7:25 am by Bart van Wezenbeek (Hoffmann Eitle)
More from our authors: Vissers Annotated European Patent Convention 2022 Edition by Kaisa Suominen, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 The Digital Economy and International Trade: Transnational Data Flows… [read post]
27 Mar 2022, 7:33 pm by Seth Davis
Two whistleblowers argued that they were eligible for an award in connection with the SEC’s investigation of Novartis AG, a pharmaceutical company, for violations of the Foreign Corrupt Practices Act. [read post]
19 Mar 2022, 2:09 pm by admin
., that an individual will become ill or die within a stated period of time or by a certain age). [read post]
6 Jan 2022, 1:22 pm by Kevin LaCroix
And there are still similar derivative cases pending against the boards of, among others, Deutsche Bank, Volkswagen, Barclays, and Novartis. [read post]
14 Nov 2021, 8:59 pm by Patent Docs
Sir Robin Jacob, Sir Hugh Laddie Chair of Intellectual Property Law, University College London; Ansgar Ohly, Professor, Ludwig Maximilian University of Munich; Roberto Rodrigues of Licks Attorneys; and Corey Salsberg of Novartis International AG. [read post]
26 Apr 2021, 7:42 am by Race to the Bottom
Novartis AG is working with Pfizer Inc. to fill vials quicker and to develop the mRNA needed for a new vaccine candidate produced by CureVA NV. [read post]
1 Feb 2021, 11:27 am by Anastasiia Kyrylenko
Singh considers two cases, Bayer v Natco and Novartis AG v Union of India, to see how compulsory licensing of pharmaceuticals and evergreening of patents are dealt with by the Indian judiciary.Part VII “Lores of IP during wartime”Arpan Banerjee and Dana Beldiman, in Chapter 14, “International Trade Mark Enforcement Under the Versailles Treaty: A Case Study of Sanatogen”, discuss how the Bombay High Court applied IP-related provisions of the… [read post]
27 Jan 2021, 11:07 am by anne
Badboy pharmaceutical giant Novartis AG and two of its subsidiaries paid the DOJ and SEC $346.7 million. [read post]
31 Dec 2020, 7:03 am by Geoff Schweller
Department of Justice announced Novartis AG, a global pharmaceutical and healthcare company based in Switzerland, agreed to pay over $300 million in sanctions to resolve FCPA charges for bribery in Greece. [read post]
24 Aug 2020, 12:00 am by Annsley Merelle Ward
Finding it difficult to keep up with an ever-changing world in the midst of a health, environmental, social and political crisis, while keeping up with patent law? [read post]
13 Aug 2020, 12:38 pm by luiza
  On June 25, 2020, the SEC announced settlement with drug company Novartis AG and its subsidiary Alcon Pte Ltd related to payments made by third parties in Asia and Europe to get doctors (including at state-owned hospitals) to prescribe Novartis drugs. [read post]
13 Aug 2020, 7:34 am by Geoff Schweller
  One of the newly posted Notices refers to a case where the SEC and Novartis AG (Novartis) settled charges that Novartis violated the Foreign and Corrupt Practices Act (FCPA). [read post]
17 Jul 2020, 8:57 am
Geneva time (CET)Connect to the meeting via:  https://washington.zoom.us/j/94575494401Participants: ·         Delia Ferreira Rubio, Chair, Transparency International ·         Klaus Moosmayer, Member of the Executive Committee Novartis, Chief Ethics, Risk and Compliance Officer, Novartis International… [read post]
1 Jul 2020, 2:02 pm by Tom Lamb
Now we want to take a closer look at the Novartis internal review of Bevou vision-related side effect cases observed in the HAWK & HARRIER clinical trials, including rare post-marketing safety reports of vasculitis. [read post]
25 Jun 2020, 12:07 pm by Mary Jane Wilmoth
Department of Justice (DOJ) announced Novartis AG (“Novartis”), a global pharmaceutical and healthcare company based in Switzerland, agreed to pay over $225 million to resolve FCPA charges for bribery in Greece. [read post]